Verification evidence is still being completed.
4D Lifetec AG
Cham, Switzerland
- Verified lead
- Giancarlo Rizzoli
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Cancer Early Detection, 4D-Comet Blood Test, and CE-IVD Oncology Diagnostics
- Review cycle
- 24 April 2026
- Full address
- Cham, Zug, Switzerland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- 4D Lifetec company page naming Giancarlo Rizzoli as CEO since January 2023.
- Editorial note
- Cham cancer-early-detection diagnostics startup with named CEO since January 2023, CE-IVD applications across four cancers, and 23.3 million CHF financing record.
Cancer Early Detection, 4D-Comet Blood Test, and CE-IVD Oncology Diagnostics
CE-IVD certified 4D Lifetest applications, 23.3 million CHF financing, Public CEO disclosure
Cham cancer-early-detection diagnostics startup with named CEO since January 2023, CE-IVD applications across four cancers, and 23.3 million CHF financing record.
4D Lifetec AG
Cancer Early Detection, 4D-Comet Blood Test, and CE-IVD Oncology Diagnostics · Diagnostic platform commercialization
Cham cancer-early-detection diagnostics startup with named CEO since January 2023, CE-IVD applications across four cancers, and 23.3 million CHF financing record.
- Lead
- Giancarlo Rizzoli (verified ↗)
- Address
- Cham, Zug, Switzerland (source ↗)
- Compliance
- CE-IVD certified 4D Lifetest applications
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Diagnostic platform commercialization
- Capabilities
- 4D-Comet Blood-Test Technology · CE-IVD Cancer Diagnostics · High-Throughput Sample Processing
- Founded
- 2014
- Headcount
- 11-50
- Company page (open ↗)
Giancarlo Rizzoli
Chief Executive Officer
Diagnostic platform commercialization
Cham, Switzerland. Cancer Early Detection, 4D-Comet Blood Test, and CE-IVD Oncology Diagnostics. Review completed on 24 Apr 2026.
Swissmedic and EU IVDR for diagnostic oversight
CE-IVD certified 4D Lifetest applications, 23.3 million CHF financing, Public CEO disclosure
Cancer Early Detection, 4D-Comet Blood Test, and CE-IVD Oncology Diagnostics
Cham cancer-early-detection diagnostics startup with named CEO since January 2023, CE-IVD applications across four cancers, and 23.3 million CHF financing record.
4D Lifetec is a Cham-based cancer-early-detection diagnostics startup with a named CEO since January 2023, CE-IVD applications across lung, breast, prostate, and colon, and a 23.3 million CHF financing round.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- VERIFIED ACTIVE 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is 4D Lifetec AG located?
- 4D Lifetec AG operates from Cham, Zug, Switzerland, Cham, Switzerland.
- Who runs 4D Lifetec AG?
- 4D Lifetec AG is led by Giancarlo Rizzoli, Chief Executive Officer. Verified 24 Apr 2026.
- What certifications does 4D Lifetec AG hold?
- 4D Lifetec AG is documented under CE-IVD certified 4D Lifetest applications.
- What does 4D Lifetec AG do?
- Cham cancer-early-detection diagnostics startup with named CEO since January 2023, CE-IVD applications across four cancers, and 23.3 million CHF financing record. Core capabilities: 4D-Comet Blood-Test Technology, CE-IVD Cancer Diagnostics, High-Throughput Sample Processing.
Related technical briefs
Briefs that name Cham as a covered market or city.
